Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials

BACKGROUND: We carried out a meta-analysis since there is not enough evidence to recommend for or against therapeutic-dose anticoagulation compared with thromboprophylaxis in noncritically ill patients hospitalized with Covid-19. METHODS: We performed a systematic literature search using PubMed, Emb...

Descripción completa

Detalles Bibliográficos
Autores principales: Ena, Javier, Valls, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435420/
https://www.ncbi.nlm.nih.gov/pubmed/36048371
http://dx.doi.org/10.1007/s10238-022-00876-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435420/
https://www.ncbi.nlm.nih.gov/pubmed/36048371
http://dx.doi.org/10.1007/s10238-022-00876-3

Ejemplares similares